Advance in Alzheimer's treatment announced

April 12, 2010 at 4:29 PM   |   Comments

DULUTH, Minn., April 12 (UPI) -- U.S. medical researchers say they have moved one step closer to being able to slow the onset and progression of Alzheimer's disease.

The scientists, in an animal study funded by the National Institute of Environmental Health Sciences, showed that by targeting the blood-brain barrier, they were able to slow the accumulation of a protein associated with the progression of the illness.

The blood-brain barrier separates the brain from circulating blood, they said, protecting the brain by removing toxic metabolites and proteins formed in the brain and preventing entry of toxic chemicals from the blood.

"This study may provide the experimental basis for new strategies that can be used to treat Alzheimer's patients," said David Miller, chief of the NIEHS Laboratory of Toxicology and Pharmacology and an author of the study. "What we've shown in our mouse models is that we can reduce the accumulation of beta-amyloid protein in the brain by targeting a certain receptor in the brain known as the pregnane X receptor, or PXR," said Miller.

The study led by University of Minnesota researcher Anika Hartz included Assistant Professor Bjorn Bauer and appears in the May issue of the journal Molecular Pharmacology.

© 2010 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Featured UPI Collection
2014: The Year in Music [PHOTOS]

2014: The Year in Music [PHOTOS]

Most Popular
Tropical storm Karina looks like the number 9 from space
Study explains why ER nurses do what they do
Neanderthals and humans interacted for thousands of years
Tech industry All Stars developing 'Star Trek'-style communication badges
Researchers dig up earliest evidence of snail-eating
Trending News